Angiotensinogen gene polymorphism near transcription start site and blood pressure: Role of a T-to-C transition at intron I

Hypertension

Volumn 34, Issue 3, 1999, Pages 430-434

  Ishigami, Tomoaki ^a   Tamura, Kouichi ^a   Fujita, Takayuki ^a   Kobayashi, Izumi ^a   Hibi, Kiyoshi ^a   Kihara, Minoru ^a   Toya, Yoshiyuki ^a   Ochiai, Hisao ^a   Umemura, Satoshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Angiotensinogen; Blood pressure; Hypertension, essential; Polymorphism; Transcription, genetic

Indexed keywords

ANGIOTENSINOGEN;

ADULT; ARTICLE; BLOOD PRESSURE; DNA POLYMORPHISM; ESSENTIAL HYPERTENSION; EXON; FEMALE; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0032887335     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.3.430     Document Type: Article

References (24)

1. Lifton RP. Molecular genetics of human blood pressure variation. Science. 1996;272:676-680. Review.
2. Jeunemaitre X, Soubrier F, Kotelevetsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:168-180.
3. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jennette JC, Coffman TM, Maeda N, Smithies O. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A. 1995;92:2735-2739.
4. Bianchi G, Tripodi MG, Casari G, Torielli L, Cusi D, Barlassina C, Stella P, Zagato L, Barber BR. Alpha-adducin may control blood pressure both in rats and humans. Clin Exp Pharmacol Physiol. 1995;22(suppl 1):S7-S9.
5. Smithies O, Kim HS. Targeted gene duplication and disruption for analyzing quantitative genetic trait in mice. Proc Natl Acad Sci U S A. 1994;91:3612-3615.
6. Caulfield M, Lavendar P, Farrall M, Munroe P, Lawson M, Turner P, Clark AJ. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 1994;330:1629-1633.
7. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, Lalouel JM. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest. 1994;93:1285-1287.
8. Caulfield M, Lavender P, Newell-Price J, Farrall M, Kamdar S, Daniel H, Lawson M, De Freitas P, Fogarty P, Clark AJ. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest. 1995;96:687-692.
9. Niu T, Xu X, Rogus J, Zhou Y, Chen C, Yang J, Fang Z, Schmitz C, Zhao J, Rao VS, Lindpaintner K. Angiotensinogen gene and hypertension in Chinese. J Clin Invest. 1998;101:188-194.
10. Kunz R, Kreutz R, Beige J, Disler A, Sharma AH. Association between the angiotensinogen 235T-variant and essential hypertension in whiles: a systematic review and methodological appraisal. Hypertension. 1997;30: 1331-1337.
11. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel JM. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest. 1997;99:1786-1797.
12. Jeunemaitre X, Inoue I, Williams C, Charru A, Tichet J, Powers M, Sharma AM, Gimenez-Roqueplo AP, Hata A, Corvol P, Laouel JM. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet. 1997;60:1448-1460.
13. Sato N, Katusya T, Rakugi H, Takami S, Nakata Y, Miki T, Higaki J, Ogihara T. Association of variants in critical core promoter element of angiotensinogen gene with increased risk of essential hypertension in Japanese. Hypertension. 1997;30:321-325.
14. Ishigami T, Umemura S, Tamura K, Hibi K, Nyui N, Kihara M, Yabana M, Watanabe Y, Sumida Y, Nagahara T, Ochiai H, Ishii M. Essential hypertension and 5′ upstream core promoter region of human angiotensinogen gene. Hypertension. 1997;30:1325-1330.
15. Nunez C, Gallgher D, Visser M, Pi-Sunyer FX, Wang Z, Heymsfeild SB. Bioimpedance analysis: evaluation of leg-to-leg system based on pressure contact footpad electrodes. Med Sci Sports Exerc. 1997;29: 524-531.
16. Hibi K, Ishigami T, Tamura K, Mizushima S, Nyui N, Fujita T, Ochiai H, Kosuge M, Watanabe Y, Yoshii Y, Kihara M, Kimura K, Ishii M, Umemura S. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension. 1998;32:521-526.
17. Norusis MJ. SPSS for the Macintosh Base System User's Guide, Release 6.1J. Cary, NC: SPSS Inc: 1996.
18. Hill WG. Estimation of linkage disequilibrium in randomly mating populations. Heredity. 1974;33:229-239.
19. Thompson EA, Deeb S, Walker D, Motulsky AG. The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am J Hum Genet. 1988;42:113-124.
20. Morgan L, Pipkin FB, Kalsheker N. DNA polymorphisms and linkage disequilibrium in the angiotensinogen gene. Hum Genet. 1996;98: 194-198.
21. Zhao YY, Zhou J, Narayanan CS, Cui Y, Kumar A, Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene. Hypertension. 1999;33:108-115.
22. Yanai K, Saito T, Hirota K, Kobayashi H, Murakami K, Fukamizu A. Molecular variation of the human angiotensinogen core promoter element located between the TATA box and transcription initiation site affects its transcriptional activity. J Biol Chem. 1997;48:30558-30562.
23. Tamura K, Umemura S, Iwamoto T, Yamaguchi S, Kobayashi S, Takeda K, Tokita Y, Takagi N, Murakami K, Fukamizu A. Molecular mechanism of adipogenic activation of the angiotensinogen gene. Hypertension. 1994;23:364-368.
24. Frederich RC Jr, Kahn BB, Peach MJ, Flier JS. Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension. 1992;19: 339-344.